LEXX Stock Price History and Quote Analysis: Insights for Investors
Lexaria Bioscience Corp.
Stock Price Today
Lexaria Bioscience Corp. (LEXX) stock surged +8.31%, trading at $3.39 on NASDAQ, up from the previous close of $3.13. The stock opened at $3.14, fluctuating between $3.14 and $3.45 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Company Information
| Employees | 5 |
| Beta | 1.028 |
| Sales or Revenue | $226.21K |
| 5Y Sales Change% | -0.813% |
| Fiscal Year Ends | August |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Lexaria Bioscience Corp. (NASDAQ: LEXX) stock price is $3.39 in the last trading session. During the trading session, LEXX stock reached the peak price of $3.45 while $3.14 was the lowest point it dropped to. The percentage change in LEXX stock occurred in the recent session was 8.31% while the dollar amount for the price change in LEXX stock was $0.26.
The NASDAQ listed LEXX is part of Biotechnology industry that operates in the broader Healthcare sector. Lexaria Bioscience Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Philip N. Ainslie Ph.D.
Advisor & Consultant
Mr. Christopher A. Bunka
Chairman & Chief Executive Officer
Mr. John M. Docherty M.Sc.
Pres & Director
Vanessa Carle
Head of Legal
Mr. Gregory John Downey CMA, CPA
Chief Financial Officer & Treasurer
Kristin Hamilton
Director of Operations
Mr. Mike Shankman
Chief Financial Officer
LEXX's closing price is 298.82% higher than its 52-week low of $0.85 where as its distance from 52-week high of $6.85 is -50.51%.
Number of LEXX employees currently stands at 5.
Official Website of LEXX is: https://www.lexariabioscience.com
LEXX could be contacted at phone 250 765 6424 and can also be accessed through its website. LEXX operates from 100 – 740 McCurdy Road, Kelowna, BC V1X 2P7, Canada.
LEXX stock volume for the day was 62.84K shares. The average number of LEXX shares traded daily for last 3 months was 188.87K.
The market value of LEXX currently stands at $53.60M with its latest stock price at $3.39 and 15.81M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com